Carmen Arenas-Cabrera, Pablo Baena-Palomino, Javier Sánchez-García, María Oliver-Romero, Yamin Chocrón-González, Manuel Caballero-Martínez
{"title":"与遗传诊断的睡眠相关的运动性癫痫:三级转诊医院的病例系列描述。","authors":"Carmen Arenas-Cabrera, Pablo Baena-Palomino, Javier Sánchez-García, María Oliver-Romero, Yamin Chocrón-González, Manuel Caballero-Martínez","doi":"10.1177/11795735211060114","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Sleep-related hypermotor epilepsy (SHE) is characterized by asymmetric tonic/dystonic posturing and/or complex hyperkinetic seizures occurring mostly during sleep. Experts agree that SHE should be considered a unique syndrome.</p><p><strong>Purpose: </strong>We present 8 cases of SHE for which a genetic diagnosis was carried out using a multigene epilepsy panel.</p><p><strong>Methods: </strong>We retrospectively screened familial and isolated cases of SHE in current follow-ups in our center.</p><p><strong>Results: </strong>We included 8 (5F/3M) patients, 5 of whom had a positive familial history of epilepsy. We identified a pathogenic mutation in <i>CHRNA4</i>, <i>CHRNB2</i>, and 3 different pathogenic changes in <i>DEPDC5</i>.</p><p><strong>Conclusions: </strong>Awareness of SHE needs to be raised, given its implications for finding an appropriate treatment, its relationship to cognitive and psychiatric comorbidities, and the opportunity to prevent the disorder in the descendants. We present our series with their clinical, radiological, electroencephalographic, and genetic characteristics, in which we found 3 pathogenic mutations in the <i>DEPDC5</i> gene but not previously reported in the literature. Identifying new pathogenic mutations or new genes responsible for SHE will facilitate a better understanding of the disease and a correct genetic counseling.</p>","PeriodicalId":15218,"journal":{"name":"Journal of Central Nervous System Disease","volume":null,"pages":null},"PeriodicalIF":2.6000,"publicationDate":"2022-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6e/5a/10.1177_11795735211060114.PMC8844731.pdf","citationCount":"1","resultStr":"{\"title\":\"Sleep-related hypermotor epilepsy with genetic diagnosis: description of a case series in a tertiary referral hospital.\",\"authors\":\"Carmen Arenas-Cabrera, Pablo Baena-Palomino, Javier Sánchez-García, María Oliver-Romero, Yamin Chocrón-González, Manuel Caballero-Martínez\",\"doi\":\"10.1177/11795735211060114\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Sleep-related hypermotor epilepsy (SHE) is characterized by asymmetric tonic/dystonic posturing and/or complex hyperkinetic seizures occurring mostly during sleep. Experts agree that SHE should be considered a unique syndrome.</p><p><strong>Purpose: </strong>We present 8 cases of SHE for which a genetic diagnosis was carried out using a multigene epilepsy panel.</p><p><strong>Methods: </strong>We retrospectively screened familial and isolated cases of SHE in current follow-ups in our center.</p><p><strong>Results: </strong>We included 8 (5F/3M) patients, 5 of whom had a positive familial history of epilepsy. We identified a pathogenic mutation in <i>CHRNA4</i>, <i>CHRNB2</i>, and 3 different pathogenic changes in <i>DEPDC5</i>.</p><p><strong>Conclusions: </strong>Awareness of SHE needs to be raised, given its implications for finding an appropriate treatment, its relationship to cognitive and psychiatric comorbidities, and the opportunity to prevent the disorder in the descendants. We present our series with their clinical, radiological, electroencephalographic, and genetic characteristics, in which we found 3 pathogenic mutations in the <i>DEPDC5</i> gene but not previously reported in the literature. Identifying new pathogenic mutations or new genes responsible for SHE will facilitate a better understanding of the disease and a correct genetic counseling.</p>\",\"PeriodicalId\":15218,\"journal\":{\"name\":\"Journal of Central Nervous System Disease\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2022-02-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6e/5a/10.1177_11795735211060114.PMC8844731.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Central Nervous System Disease\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1177/11795735211060114\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Central Nervous System Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/11795735211060114","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
Sleep-related hypermotor epilepsy with genetic diagnosis: description of a case series in a tertiary referral hospital.
Introduction: Sleep-related hypermotor epilepsy (SHE) is characterized by asymmetric tonic/dystonic posturing and/or complex hyperkinetic seizures occurring mostly during sleep. Experts agree that SHE should be considered a unique syndrome.
Purpose: We present 8 cases of SHE for which a genetic diagnosis was carried out using a multigene epilepsy panel.
Methods: We retrospectively screened familial and isolated cases of SHE in current follow-ups in our center.
Results: We included 8 (5F/3M) patients, 5 of whom had a positive familial history of epilepsy. We identified a pathogenic mutation in CHRNA4, CHRNB2, and 3 different pathogenic changes in DEPDC5.
Conclusions: Awareness of SHE needs to be raised, given its implications for finding an appropriate treatment, its relationship to cognitive and psychiatric comorbidities, and the opportunity to prevent the disorder in the descendants. We present our series with their clinical, radiological, electroencephalographic, and genetic characteristics, in which we found 3 pathogenic mutations in the DEPDC5 gene but not previously reported in the literature. Identifying new pathogenic mutations or new genes responsible for SHE will facilitate a better understanding of the disease and a correct genetic counseling.